Works matching IS 1386341X AND DT 2022 AND VI 25 AND IP 6
Results: 23
Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 997, doi. 10.1007/s11102-022-01284-2
- By:
- Publication type:
- Article
Long-term hepatic and cardiac health in patients diagnosed with Sheehan's syndrome.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 971, doi. 10.1007/s11102-022-01282-4
- By:
- Publication type:
- Article
Impact of histopathological classification of non-functioning adenomas on long term outcomes: comparison of the 2004 and 2017 WHO classifications.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 988, doi. 10.1007/s11102-022-01281-5
- By:
- Publication type:
- Article
Long-term efficacy and safety of osilodrostat in Cushing's disease: final results from a Phase II study with an optional extension phase (LINC 2).
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 959, doi. 10.1007/s11102-022-01280-6
- By:
- Publication type:
- Article
The role of stereotactic radiosurgery in the multidisciplinary management of pituitary metastases.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 948, doi. 10.1007/s11102-022-01279-z
- By:
- Publication type:
- Article
Serum copeptin levels at day two after pituitary surgery and ratio to baseline predict postoperative central diabetes insipidus.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 1004, doi. 10.1007/s11102-022-01278-0
- By:
- Publication type:
- Article
Idiopathic central diabetes insipidus in a large cohort of patients: the hypopituitarism ENEA rare observational (HEROS) study.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 982, doi. 10.1007/s11102-022-01277-1
- By:
- Publication type:
- Article
Changing the name of diabetes insipidus.
- Published in:
- 2022
- By:
- Publication type:
- Letter
Problem-solving therapy can reduce psychological distress in patients with Cushing's disease: a randomized controlled trial.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 891, doi. 10.1007/s11102-022-01275-3
- By:
- Publication type:
- Article
High prevalence of overweight/obesity and dyslipidemia in patients with intracranial germ cell tumors.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 938, doi. 10.1007/s11102-022-01274-4
- By:
- Publication type:
- Article
Influence of growth hormone therapy on germinoma survivors.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 854, doi. 10.1007/s11102-022-01273-5
- By:
- Publication type:
- Article
Characterization of sporadic somatotropinomas with high GIP receptor expression.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 903, doi. 10.1007/s11102-022-01272-6
- By:
- Publication type:
- Article
Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 868, doi. 10.1007/s11102-022-01270-8
- By:
- Publication type:
- Article
Historical and future trends in emergency pituitary referrals: a machine learning analysis.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 927, doi. 10.1007/s11102-022-01269-1
- By:
- Publication type:
- Article
Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with case examples.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 795, doi. 10.1007/s11102-022-01268-2
- By:
- Publication type:
- Article
Demonstration of the inferior intercavernous sinus is closely linked to the extent of pneumatization of the sphenoid sinus: useful information for the pituitary surgeon.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 861, doi. 10.1007/s11102-022-01267-3
- By:
- Publication type:
- Article
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 831, doi. 10.1007/s11102-022-01266-4
- By:
- Publication type:
- Article
Levoketoconazole in the treatment of patients with endogenous Cushing's syndrome: a double-blind, placebo-controlled, randomized withdrawal study (LOGICS).
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 911, doi. 10.1007/s11102-022-01263-7
- By:
- Publication type:
- Article
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 882, doi. 10.1007/s11102-022-01259-3
- By:
- Publication type:
- Article
Treatment of non-functioning pituitary adenoma with cabergoline: a systematic review and meta-analysis.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 810, doi. 10.1007/s11102-022-01257-5
- By:
- Publication type:
- Article
Determinants of skeletal fragility in acromegaly: a systematic review and meta-analysis.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 780, doi. 10.1007/s11102-022-01256-6
- By:
- Publication type:
- Article
Generating novel pituitary datasets from open-source imaging data and deep volumetric segmentation.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 842, doi. 10.1007/s11102-022-01255-7
- By:
- Publication type:
- Article
Giant prolactinoma in children and adolescents: a single-center experience and systematic review.
- Published in:
- Pituitary, 2022, v. 25, n. 6, p. 819, doi. 10.1007/s11102-022-01250-y
- By:
- Publication type:
- Article